Results 31 to 40 of about 3,492,596 (401)

Drug repurposing strategies in the development of potential antifungal agents

open access: yesApplied Microbiology and Biotechnology, 2021
The morbidity and mortality caused by invasive fungal infections are increasing across the globe due to developments in transplant surgery, the use of immunosuppressive agents, and the emergence of drug-resistant fungal strains, which has led to a ...
Qian Zhang   +4 more
semanticscholar   +1 more source

Novel Natural and Synthetic Anticandidal Therapeutic Peptides to Combat Drug-Resistant Infections

open access: yesMedical Sciences Forum, 2023
Candida species are considered as common flora of the healthy human mycobiome and occur on skin, mucosal surfaces of gastrointestinal and genitourinary tracks. Pathogenic Candida spp., reported to cause skin, vaginal and oral infections. Extensive use of
Deepika Sharma
doaj   +1 more source

Antifungal Combinations in Dermatophytes

open access: yesJournal of Fungi, 2021
Dermatophytes are the most common cause of fungal infections worldwide, affecting millions of people annually. The emergence of resistance among dermatophytes along with the availability of antifungal susceptibility procedures suitable for testing ...
Lucia Brescini   +3 more
doaj   +1 more source

New Antifungal Agents with Azole Moieties. [PDF]

open access: yesPharmaceuticals (Basel), 2022
Fungal conditions affect a multitude of people worldwide, leading to increased hospitalization and mortality rates, and the need for novel antifungals is emerging with the rise of resistance and immunocompromised patients.
Teixeira MM   +3 more
europepmc   +2 more sources

Aspiring Antifungals: Review of Current Antifungal Pipeline Developments

open access: yesJournal of Fungi, 2020
Invasive fungal infections are associated with significant morbidity and mortality, and their management is restricted to a variety of agents from five established classes of antifungal medication.
Thomas J. Gintjee   +2 more
doaj   +1 more source

Variability in antifungal and antiviral use in hospitalized children [PDF]

open access: yes, 2017
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S   +6 more
core   +2 more sources

Use of antifungal drugs in hematology

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2012
Invasive fungal disease represents a major complication in hematological patients. Antifungal agents are frequently used in hematologic patients for different purposes.
Marcio Nucci
doaj   +1 more source

Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris [PDF]

open access: yes, 2019
The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated our consciousness. The global threat from this multidrug-resistant yeast has generated a call to arms from within the medical mycology community.
Kean, Ryan, Ramage, Gordon
core   +2 more sources

Improving of Robotic Virtual Agent's errors that are accepted by reaction and human's preference [PDF]

open access: yesInternational Conference on Social Robotics, Dec 2023, 2023
One way to improve the relationship between humans and anthropomorphic agents is to have humans empathize with the agents. In this study, we focused on a task between an agent and a human in which the agent makes a mistake. To investigate significant factors for designing a robotic agent that can promote humans empathy, we experimentally examined the ...
arxiv   +1 more source

Ecotoxicity and Mutagenicity Assessment of Novel Antifungal Agents VT-1161 and T-2307. [PDF]

open access: yesMolecules
Antifungal substances are essential for managing fungal infections in humans, animals, and plants, and their usage has significantly increased due to the global rise in fungal infections.
Padilla Suarez EG   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy